Online citations, reference lists, and bibliographies.
← Back to Search

Comparison Of Quantum Dot Biodistribution With A Blood-flow-limited Physiologically Based Pharmacokinetic Model.

H. A. Lee, T. Leavens, S. Mason, N. Monteiro-Riviere, J. Riviere
Published 2009 · Materials Science, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
A physiologically based pharmacokinetic model with partition coefficients estimated from quantum dot (QD) 705 biodistribution was compared with the biodistribution of other QDs in mice and rats to determine the model's predictive ability across QD types, species, and exposure routes. The model predicted the experimentally observed persistence of QDs in tissues but not early time profiles or different QD biodistribution. Therefore, more complex models will be needed to better predict QD biodistribution in vivo.



This paper is referenced by
10.1002/jcph.1715
The Current Landscape of Novel Formulations and the Role of Mathematical Modeling in Their Development
Nicolas Cottura (2020)
10.1016/j.jconrel.2020.07.014
Fast processes of nanoparticle blood clearance: Comprehensive study.
I. Zelepukin (2020)
10.1016/j.ejps.2020.105639
Population pharmacokinetic modelling of indium-based quantum dot nanoparticles: preclinical in vivo studies
E. Yaghini (2020)
10.1021/acsnano.9b08142
Meta-Analysis of Nanoparticle Delivery to Tumors Using a Physiologically Based Pharmacokinetic Modeling and Simulation Approach
Yi-Hsien Cheng (2020)
10.3390/nano10071267
Current Approaches and Techniques in Physiologically Based Pharmacokinetic (PBPK) Modelling of Nanomaterials
W. Utembe (2020)
10.1016/b978-0-12-818596-4.00001-1
A history and recent efforts of selected physiologically based pharmacokinetic modeling topics
Zhoumeng Lin (2020)
10.1038/s41598-019-51789-3
dendPoint: a web resource for dendrimer pharmacokinetics investigation and prediction
L. M. Kaminskas (2019)
10.1016/j.taap.2019.114765
Endocytosis mechanism in physiologically-based pharmacokinetic modeling of nanoparticles.
Linjing Deng (2019)
10.7150/thno.34509
Research tools for extrapolating the disposition and pharmacokinetics of nanomaterials from preclinical animals to humans
M. Valic (2019)
10.1016/J.IMPACT.2018.02.003
Directions in QPPR development to complement the predictive models used in risk assessment of nanomaterials
J. Quik (2018)
10.1080/17435390.2018.1476986
Modeling gold nanoparticle biodistribution after arterial infusion into perfused tissue: effects of surface coating, size and protein corona
J. Riviere (2018)
10.2147/IJN.S157210
Physiologically based pharmacokinetic modeling of nanoceria systemic distribution in rats suggests dose- and route-dependent biokinetics
Ulrika Carlander (2018)
10.1002/wnan.1440
Biological and environmental surface interactions of nanomaterials: characterization, modeling, and prediction.
R. Chen (2017)
Etude toxicogénomique de nanovecteurs de silice mésoporeuse : relation entre décoration et toxicité
C. Pisani (2017)
10.1016/j.tiv.2017.04.020
Biocorona formation on gold nanoparticles modulates human proximal tubule kidney cell uptake, cytotoxicity and gene expression.
M. T. Ortega (2017)
10.7282/T3WS8WPV
Physiologically based pharmacokinetic modeling of nanoparticles in rodents
X. Li (2017)
10.1016/j.addr.2016.08.012
Building the design, translation and development principles of polymeric nanomedicines using the case of clinically advanced poly(lactide(glycolide))-poly(ethylene glycol) nanotechnology as a model: An industrial viewpoint.
H. R. Lakkireddy (2016)
10.1021/acs.nanolett.5b03854
Physiologically Based Pharmacokinetic Model for Long-Circulating Inorganic Nanoparticles.
X. Liang (2016)
10.1208/s12248-016-0010-3
Physiologically Based Pharmacokinetic (PBPK) Modeling of Pharmaceutical Nanoparticles
Min Li (2016)
10.1002/9783527800681.CH15
Computational Predictive Models for Nanomedicine
M. Siccardi (2016)
10.3109/17435390.2015.1027314
A physiologically based pharmacokinetic model for polyethylene glycol-coated gold nanoparticles of different sizes in adult mice
Z. Lin (2016)
Physiologically based modelling of nanoparticle biodistribution and biokinetics
Ulrika Carlander (2016)
10.1186/s12989-016-0156-2
In vivo biodistribution and physiologically based pharmacokinetic modeling of inhaled fresh and aged cerium oxide nanoparticles in rats
Dingsheng Li (2016)
10.2147/IJN.S94370
Toward a general physiologically-based pharmacokinetic model for intravenously injected nanoparticles
Ulrika Carlander (2016)
10.1016/j.envint.2016.07.016
Frameworks and tools for risk assessment of manufactured nanomaterials.
D. Hristozov (2016)
10.7508/aojnmb.2016.02.005
Physiologically Based Pharmacokinetic (PBPK) Model for Biodistribution of Radiolabeled Peptides in Patients with Neuroendocrine Tumours
Radovan Gospavić (2016)
10.1007/978-981-10-0818-4_2
Biodegradable Nanoparticles and Their In Vivo Fate
A. Kumari (2016)
10.2217/nnm.15.177
A computational framework for interspecies pharmacokinetics, exposure and toxicity assessment of gold nanoparticles.
Z. Lin (2016)
10.7282/T3M90BJ3
Computational modeling of nanoparticle distribution and toxicity in biological systems
Dwaipayan Mukherjee (2015)
A Physiologically Based Pharmacokinetic Model Study of the Biological Fate, Transport and Behavior of Engineered Nanoparticles
Dingsheng Li (2015)
10.1039/C5RA05889A
Biophysical, biopharmaceutical and toxicological significance of biomedical nanoparticles
S. Aula (2015)
10.1002/wnan.1304
Pharmacokinetics of metallic nanoparticles.
Zhoumeng Lin (2015)
See more
Semantic Scholar Logo Some data provided by SemanticScholar